Table 2.
Isolate ID |
Animal species |
MIC(μg ml−1)a for |
QRDRb |
PMQRc |
O-serotype |
Phylogenetic group |
MIC (μg ml−1)a for |
β-Lactamase (β-lactamase gene) |
PFGE typed |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ciprofloxacin |
Nalidixic acid |
gyrA |
parC |
parE |
Cefotaxime |
|||||||||
Ser83 |
Asp87 |
Ser80 |
Glu84 |
Ser458 |
||||||||||
51–1 |
Dog |
2 |
>256 |
Leu83 |
- |
- |
- |
- |
qnrS, aac-(6′)-Ib-cr |
UT |
D |
<1 |
9′ |
|
64–2 |
Dog |
2 |
256 |
Leu83 |
- |
- |
- |
- |
qnrS, aac-(6′)-Ib-cr |
UT |
D |
<1 |
9′′′ |
|
72–1 |
Cat |
2 |
>256 |
Leu83 |
- |
- |
- |
- |
qnrS, aac-(6′)-Ib-cr |
UT |
D |
<1 |
9′′′′ |
|
63–1 |
Dog |
3 |
>256 |
Leu83 |
- |
- |
- |
- |
qnrS, aac-(6′)-Ib-cr |
UT |
D |
<1 |
9′′ |
|
32–1 |
Dog |
3 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
A |
4 |
AmpC (CMY-2) |
6 |
|
26–1 |
Cat |
4 |
>256 |
Leu83 |
Tyr87 |
Ile80 |
- |
- |
O157e |
B1 |
<1 |
10 |
||
89–1 |
Cat |
4 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B1 |
<1 |
13 |
||
37E-1 |
Cat |
6 |
>256 |
Leu83 |
- |
Ile80 |
- |
- |
qnrS, aac-(6′)-Ib-cr |
UT |
D |
<1 |
9 |
|
24–1 |
Dog |
6 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
aac-(6′)-Ib-cr |
UT |
D |
32 |
ESBL (CTX-M-14) |
16 |
28–1 |
Cat |
6 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B1 |
<1 |
12 |
||
88–1 |
Cat |
8 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B1 |
<1 |
5 |
||
107–1 |
Dog |
8 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B1 |
<1 |
4 |
||
108–1 |
Dog |
8 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B1 |
<1 |
4′ |
||
57E-1 |
Cat |
12 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B1 |
<1 |
11 |
||
40–1 |
Cat |
16 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B1 |
<1 |
12′ |
||
2E-1 |
Cat |
16 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B2 |
<1 |
3 |
||
73–1 |
Cat |
16 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
UT |
B2 |
<1 |
3′ |
||
13–1 |
Dog |
24 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
- |
qnrB |
O1 |
D |
32 |
AmpC (DHA-1) |
1 |
7–1 |
Cat |
32 |
>256 |
Leu83 |
Tyr87 |
Ile80 |
- |
Ala458 |
aac-(6′)-Ib-cr |
UT |
D |
16 |
ESBL (CTX-M-14, TEM-1) |
7 |
42–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
D |
<1 |
2 |
||
85–1 |
Cat |
>32 |
>256 |
Leu83 |
Tyr87 |
Ile80 |
- |
Ala458 |
UT |
D |
>32 |
nd r |
8 |
|
76–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
83–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
86–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
96–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
97–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
98–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
105–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
106–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14 |
||
70–1 |
Dog |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
- |
Ala458 |
UT |
B1 |
<1 |
14′ |
||
104–1 |
Cat |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
Gly84 |
- |
aac-(6′)-Ib-cr |
UT |
D |
16 |
ESBL (CTX-M-14, TEM-1) |
15 |
87–1 |
Cat |
>32 |
>256 |
Leu83 |
Asn87 |
Ile80 |
Val84 |
- |
aac-(6′)-Ib-cr |
O25 |
B2 |
>32 |
ESBL (CTX-M-27) |
17 |
a, MICs for ciprofloxacin, nalidixic acid and cefotaxim were confirmed with an E-test.
b, Mutation in gyrB was not found.
c, PMQR: qnrA [14], qnrB [14], qnrC [14], qnrD [16], qnrS [14], qepA [14], oqxA [15], oqxB [15] and aac(6')-Ib-cr [14] were tested.
d, Prime symbols (', '', ''', '''' indicate >80 % similarity between band patterns.
e, Negative for the shiga toxin gene.
f, β-Lactamase phenotype and β-lactamase genes were not detected.